KORU Medical Systems, Inc.
KRMD
$2.47
-$0.02-0.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.00% | 16.80% | 21.54% | 10.89% | -2.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.00% | 16.80% | 21.54% | 10.89% | -2.16% |
| Cost of Revenue | 14.74% | 12.51% | -3.20% | -4.66% | -12.60% |
| Gross Profit | 28.44% | 19.43% | 40.94% | 23.06% | 6.20% |
| SG&A Expenses | 16.24% | 10.90% | 0.31% | -1.26% | 5.31% |
| Depreciation & Amortization | -7.36% | 5.46% | 2.35% | 8.59% | 21.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.13% | 12.38% | -5.30% | -2.78% | -4.80% |
| Operating Income | 27.67% | 4.90% | 63.03% | 35.83% | 12.50% |
| Income Before Tax | 22.89% | 5.26% | 68.06% | 35.21% | 16.19% |
| Income Tax Expenses | -99.95% | -- | -- | -- | 1,352.61% |
| Earnings from Continuing Operations | 79.09% | -15.53% | 60.39% | 19.70% | -277.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.09% | -15.53% | 60.39% | 19.70% | -277.70% |
| EBIT | 27.67% | 4.90% | 63.03% | 35.83% | 12.50% |
| EBITDA | 24.15% | 6.32% | 67.65% | 39.16% | 15.26% |
| EPS Basic | 79.14% | -15.00% | 60.51% | 20.00% | -275.00% |
| Normalized Basic EPS | 24.19% | 5.70% | 68.16% | 34.24% | 16.57% |
| EPS Diluted | 79.14% | -15.00% | 60.51% | 20.00% | -275.00% |
| Normalized Diluted EPS | 24.19% | 5.70% | 68.16% | 34.24% | 16.57% |
| Average Basic Shares Outstanding | 0.36% | 0.46% | 0.45% | 0.49% | 0.66% |
| Average Diluted Shares Outstanding | 0.36% | 0.46% | 0.45% | 0.49% | 0.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |